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non-Hispanic whites in the United States
(1989–2018)
Alberto Barcelo1,2*, Linda Duffett-Leger3, Maria Pastor-Valero4,5, Juliana Pereira1, Fernando A. B. Colugnati1 and
Edward Trapido6

Abstract
Background: Cancer mortality in the U.S. has fallen in recent decades; however, individuals with lower levels of
education experienced a smaller decline than more highly educated individuals. This analysis aimed to measure the
influence of education lower than a high school diploma, on cancer amenable mortality among Non-Hispanic
Whites (NHW) and Non-Hispanic Blacks (NHB) in the U.S. from 1989 to 2018.
Methods: We analyzed data from 8.2 million death certificates of men and women who died from cancer between
1989 and 2018. We examined 5-year and calendar period intervals, as well as annual percent changes (APC). APC
was adjusted for each combination of sex, educational level, and race categories (8 models) to separate the general
trend from the effects of age.
Results: Our study demonstrated an increasing mortality gap between the least and the most educated NHW and
NHB males and females who died from all cancers combined and for most other cancer types included in this
study. The gap between the least and the most educated was broader among NHW males and females than
among NHB males and females, respectively, for most malignancies.
Conclusions: In summary, we reported an increasing gap in the age-adjusted cancer mortality among the most
and the least educated NHW and NHB between 25 and 74 years of age. We demonstrated that although NHB
exhibited the greatest age-adjusted mortality rates for most cancer locations, the gap between the most and the
least educated was shown for NHW.

Introduction
Low education is a strong predictor of high mortality in
the United States (U.S.). The mortality gap between
poorly and highly educated U.S. citizens has dramatically
increased in recent years, particularly in specific subpopulations [1–3]. Mortality in the U.S. has declined more
* Correspondence: abarcelo@med.miami.edu
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Department of Public Health Science, Miller School of Medicine, University
of Miami, P.O. Box 414037, Miami Beach, FL 33141, USA
Full list of author information is available at the end of the article

dramatically among the better educated than among less
educated individuals [1–4].
Globally, cancer mortality increased from 7.7 million
deaths in 2011 to 9.6 million deaths in 2017 [5, 6]. In
the U.S., cancer mortality rates declined by 29%, from
1991 to 2017 [7]. However, it did not reduce equally in
all U.S. population segments [8]. A greater prevalence of
cancer and lower screening rates has been reported
among Non-Hispanic Blacks (NHB) and individuals with
less than high school education, compared to Non-
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Hispanic Whites (NHW) and their better-educated
peers, respectively [9–17].
NHW individuals born in 1980s with a lower than
grade 12 education, presented cancer amenable mortality
rates almost three times higher than their counterparts
born in 1955 with a comparable level of education; however, during the same period, no significant differences
were found among the most educated NHW individuals
[8]. A greater prevalence of cancer and lower screening
rates have been found among NHB and those with education lower than high school compared to NHW and
their highly educated peers, respectively [9–11]. Potentially modifiable social determinants of health, such as
access to health care services and socioeconomic status
(SES), are associated with cancer mortality, screening,
and treatment disparities among vulnerable populations
in the U.S. [8, 12–17].
Compared to neighborhoods with favorable economic
indicators, higher breast cancer mortality rates have
been reported in places where people with unfavorable
social determinants of health clustered (lower education, lower household income, and higher unemployment and proportion of uninsured population) [18–21].
The difference in breast cancer mortality between
NHW and NHB women has been linked to education,
family income, access to primary care physicians, and
mammography in communities [22]. Complex interactions between race and different SES such as education
and neighborhood SES (nSES) were identified as a factor in higher breast cancer mortality among various racial groups [23].
Implementation of the Affordable Care Act (ACA) has
had a measurable impact on improving early diagnosis
of cancer among low income populations [24, 25], particularly in some of the more preventable or treatable
cancers such as cervical, breast, and colorectal cancer
[26]. The aim of this analysis was to measure the influence of education lower than a high school diploma on
cancer amenable mortality among NHW and NHB in
the U.S. between 1989 and 2018.

Methods
Study design and population

We used a time-series design to analyze data from death
certificates of 8.2 million men and women who died
from cancer between 1989 and 2018. We used for our
analysis, death certificate data from the U.S. National
Center for Health Statistics (NCHS) and U.S. population
estimates by age, gender, and ethnicity from the U.S.
Census Bureau [27]. Information on race and education
for a death certificate is reported by funeral directors,
family members or taken from medical records (1989 to
2018) [28].
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Variables and data collection

We selected mortality data due to specific cancer types,
potentially amenable to appropriate health care, based
on a modified version of the list published by Nolte
et al. [29], as shown in Table 1.
Data on attained education and ethnicity were extracted from the death certificate databases. Counts of
deaths due to colon, lung, breast, the body of the uterus,
cervical, testis, prostate, Hodgkin’s disease, leukemia as
well other cancers, were used to calculate age-adjusted
mortality rates from 1989 to 2018, by year, sex, attained
education (less than grade 12 or grade 12 and more)
among NHW and NHB. We dichotomized the education
variable into two groups of less than 12 years of education and 12 years or more of schooling, consistent with
previous researchers [30, 31]. This approach was taken
since the highest mortality rates were reported among
those with less than 12 years of schooling [32, 33], suggesting that not completing a high school education was
a critical threshold for the risk of mortality in the U.S.
Furthermore, attaining a high school diploma is an important step in decreasing yearly mortality rates among
adults in the U.S. [34]. Dichotomizing the education
variable facilitated a simple presentation of data [30–33,
35].
Individuals with less than 25 or more than 74 years of
age and those with missing or unknown education, or
races other than NHW or NHB, were excluded.
Overall, only 5.9% of available records of cancer
deaths among NHW and NHB were excluded from
the analysis because the level of education was classified as unknown. From the 16.7 million overall cancer
deaths in the U.S. (1989–2018), only 0.9%, the variable race was classified as unknown. We included 8.2
million deaths from a pool of 8.7 death certificates
for NHW and NHB, who died from cancer between
1989 and 2018.

Statistical analysis

Age-and-sex standardized rates were calculated using
the 2000 U.S. census population as a standard (https://
seer.cancer.gov/stdpopulations/stdpop.19ages.html). All
analyses were restricted to individuals aged 25 to 74
years who died from cancers. We added deaths from
prostate cancer to Nolte’s list since this was the only
major cause of cancer absent from their list [36].
We examined 5-year and calendar period intervals and
annual percent changes (APC) adjusted for each combination of sex, educational level, and race categories to
separate the general trend from the effects of age. Data
analysis was conducted using the Joinpoint Regression
Program (https://surveillance.cancer.gov/joinpoint/) as
well as SPSS-26 and Stata-14 [37–39].
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Table 1 Causes of death considered amenable to health care
Cause of death

Age

International Classification of Disease
10th revision

Comment

Malignant neoplasm of colon and rectum

0–74

153–4

C18–21

–

Malignant melanoma and other neoplasm of skin

0–74

173

C43-C44

–

Malignant neoplasm of the breast

0–74

174

C50

Females only

Malignant of the cervix uteri

0–74

180

C53

Females only

Malignant of the body of uterus

0–74

179–182

C54-C55

Females only

Malignant neoplasm of the testis

0–74

186

C62

Males only

Malignant neoplasm of the prostate

0–74

185

C61

Males only

Malignant neoplasm of the trachea, bronchus, and lung

0–74

162

C33-C34

–

Hodgkin’s disease

0–74

201

C81

–

Leukemia

0–74

204–8

C91-C05

–

Results
All amenable age-adjusted cancer mortality rates, between 1989 and 2018, increased in both sexes and races
with education less than 12 years, while they decreased
among those with 12 or more years of education (Fig. 1
A-B).
Age-adjusted amenable colon and rectum cancer mortality rates were lower among the most educated than
among their least educated peers for both races and
sexes (Fig. 1, C-D). Age-adjusted mortality rates for
colon and rectum cancer for both sexes and races increased among the least educated while decreasing
among the most educated. These trends were statistically
significant (Table 2).
Age-adjusted skin cancer mortality rates (Fig. 2, A-B)
were two to three times higher among NHW than their
NHB peers. NHW men and women with lower levels of
education presented lower mortality rates than their
higher-educated peers between 1989 and 1998; however,
trends for both NHW genders reversed in 1999–2018,
showing consistently higher age-adjusted mortality rates
among the less educated compared to the most
educated.
Age-adjusted mortality due to lung and trachea cancer
was three times higher among the less educated compared their most educated peers (Fig. 2, C-D). The APC
analysis indicated statistically significant decreasing
trends for NHW and NHB males and NHB women with
12 or more years of education (Table 2).
Age-adjusted amenable mortality rates for Hodgkin’s
disease and leukemia were the lowest for NHW males
and females among the most educated, and they were
comparably low for NHB of the same gender and education (Fig. 3, A-B, C-D). The least educated NHB men
and women presented the highest age-adjusted mortality
rates for Hodgkin’s disease during the study period.
Age-adjusted cancer of the testis mortality rates (Fig. 4,
A) was the highest among the less educated NHW and

9th revision

NHB than the most educated peers. NHB men had ageadjusted cancer of the testis rates between 50% and 66%
lower than NHW males. The age-adjusted mortality rate
for prostate cancer (Fig. 4, B) was more than double
among NHB men than NHW men.
Breast cancer mortality rates (Fig. 5, A) were the lowest
among the most educated NHW, beginning 2000 when
there was an increasing trend for the least educated NHW
and NHB, respectively. The highest mortality rates during
the study period were observed among the most educated
NHB; however, there was a significant decreasing trend
(APC − 1.4, p < 0.01) among NHB women with an education of 12 years or higher (Table 2).
Age-adjusted mortality rates for cancer of the cervix
(Fig. 5, B) were two to three times higher among the
least educated than their most educated peers of both
races, the gap was the biggest among NHW. The APC
analysis indicated a statistically significant increasing
trend among the least educated NHW (Table 2).
The age-adjusted mortality rate for the body of the
uterus (Fig. 5 C) increased among females of both races
and education levels; however, NHB with an education
of 12 years and higher had higher mortality rates than all
other groups. All four increasing trends were statistically
significant (Table 2).
All other cancer age-adjusted mortality rates increased
(Fig. 6 A-B) among the less educated and decreased
among the most educated of both races and genders. APC
indicated a statistically significant increasing trend among
the less educated NHW men and women (Table 2).

Discussion
Our study demonstrated an increased mortality gap between the least and the most educated who died from
most types of cancers. The gap between the least and
most educated was broader for most malignancies
among NHW than among NHB, respectively, suggesting
delayed death from some of the most frequent cancers
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Fig. 1 Adjusted amenable mortality rate (X100,000) due all cancer and cancer of colon and rectum, with Joinpoint Regression (modeled line of
trends), among NHW & NHB by gender, period and education level. United States, 1989–2018. < 12: less than 12 years of education; 12+: 12 years
of education or more. NHW: Non-Hispanic Whites; NHB: Non-Hispanic Blacks

among individuals in the U.S. with grade 12 or higher
education [40].
Among the limitation of our study was the lack of
additional variables, such as income or access to health
insurance. Moreover, we relayed on the level of education reported on death certificates, which are subject to
reporter’s recall bias. Besides that, there are controversial
reports regarding the reliability of the level of education

information provided by death certificates. Research has
demonstrated that a proportion of cases who attended
high school are reported as graduated, even though they
did not achieve a diploma. That would overestimate the
number of high school graduates in our sample, especially among NHB. But this bias, however, is unlikely to
change our results [41, 42] since the difference we found
appears to be consistent across time, race, and cancer

Barcelo et al. BMC Cancer

(2021) 21:907

Page 5 of 13

Table 2 Average annual percentage change APC (and 95%-CI) in mortality by type of cancer among NHW and NHB, by gender and
education level. United States, 1989–2018
Level of education
< 12 Years
Race

APC

12 + Years

95%-CI

APC

Lower

Upper

t

p

95%-CI
Lower

Upper

t

p

− 1.7

− 0.5

−5.2

0.0

Males
All cancers

NHW

2.0

1.0

3.1

5.6

0.0

−1.1

NHB

0.5

−0.9

1.9

0.9

0.4

−2.1

− 3.0

− 1.2

− 6.5

0.0

Colon & rectum

NHW

1.8

1.0

2.7

6.1

0.0

−1.6

−2.2

−0.9

− 6.7

0.0

NHB

1.5

−0.2

3.3

2.5

0.1

−1.6

−2.6

−0.6

−4.4

0.0

Skin

NHW

2.6

1.2

4.0

5.3

0.0

−0.4

−1.2

0.4

− 1.4

0.2

NHB

−0.6

−1.5

0.4

−1.7

0.2

−2.4

−2.9

−1.9

−13.1

0.0

Trachea, bronchus & lung

NHW

1.5

0.3

2.8

3.6

0.0

−2.1

−3.1

−1.1

−5.7

0.0

NHB

−0.2

−1.8

1.5

− 0.3

0.8

− 3.2

−4.4

−2.0

−7.2

0.0

Hodgkin’s disease

NHW

1.1

−1.0

3.2

1.4

0.2

−2.8

−3.3

−2.3

−16.9

0.0

NHB

0.3

−1.7

2.3

0.4

0.7

−3.0

−4.1

−1.8

−7.1

0.0

Leukemia

NHW

1.8*

0.4

3.1

3.7

0.0

−1.0

−2.0

−0.1

−3.1

0.0

NHB

0.7

−0.9

2.3

1.2

0.3

−1.6

−2.5

−0.7

−5.1

0.0

Testis

NHW

4.3

1.3

7.4

4.0

0.0

0.3

−0.5

1.0

1.0

0.4

NHB

1.4

−3.4

6.4

0.8

0.5

0.1

−2.6

2.8

0.1

1.0

Prostate

NHW

−0.3

−0.4

−0.2

−7.3

0.0

−2.5

−3.3

−1.6

− 8.1

0.0

NHB

−0.3

−2.2

1.6

−0.5

0.6

−2.7

−3.8

−1.6

−6.7

0.0

Other types

NHW

2.8

1.8

3.8

7.8

0.0

−0.2

−0.7

0.3

−1.2

0.3

0.9

−0.2

2.0

2.4

0.1

−1.3

−2.0

−0.6

−5.1

0.0

NHB

Females
All cancers

Colon & rectum

Skin

Trachea, bronchus & lung

Hodgkin’s Disease

Leukemia

Breast

Cervix uteri

Body of uterus

Other types

NHW

2.6

1.3

3.9

5.4

0.0

−0.9

−1.6

−0.3

−3.9

0.0

NHB

0.7

−0.2

1.7

2.1

0.1

−1.4

−2.1

−0.6

−5.2

0.0

NHW

1.9

0.9

2.9

5.4

0.0

−1.5

−2.2

−0.9

−6.4

0.0

NHB

0.5

−0.6

1.6

1.2

0.3

−2.0

−2.9

−1.1

−6.0

0.0

NHW

2.6

1.0

4.3

4.5

0.0

−0.4

−1.3

0.4

− 1.4

0.2

NHB

1.1

−0.3

2.5

2.1

0.1

−2.1

−3.0

−1.3

−6.9

0.0

NHW

3.4

1.6

5.3

5.2

0.0

−0.9

−2.2

0.3

−2.1

0.1

NHB

1.1

−0.6

2.8

1.8

0.2

−1.9

−3.1

−0.7

−4.3

0.0

NHW

2.2

0.9

3.6

4.6

0.0

−2.7

−4.4

−1.0

−4.5

0.0

NHB

0.8

−1.0

2.7

1.2

0.3

−2.5

−3.8

−1.3

−5.5

0.0
0.0

NHW

1.8

0.5

3.1

3.8

0.0

−1.1

−1.9

−0.2

−3.4

NHB

0.3

−0.6

1.3

1.0

0.4

−1.4

−2.0

−0.7

−5.9

0.0

NHW

1.0

−0.3

2.2

2.2

0.1

−1.8

−2.2

−1.3

− 11.3

0.0

NHB

0.5

−0.5

1.4

1.4

0.2

−1.4

−2.1

−0.7

−5.3

0.0

NHW

3.1

2.0

4.2

7.9

0.0

−0.4

−0.9

0.2

−1.9

0.1

NHB

−0.4

−1.3

0.4

−1.4

0.2

−2.2

−3.0

−1.4

−7.4

0.0

NHW

3.1

2.3

4.0

10.3

0.0

1.3

1.0

1.5

15.9

0.0

NHB

2.3

1.8

2.7

14.7

0.0

1.5

1.1

1.9

10.1

0.0

NHW

2.4

1.2

3.7

5.7

0.0

−0.5

−1.2

0.1

−2.3

0.1

NHB

0.7

−0.1

1.6

2.4

0.1

−1.1

−1.8

−0.4

−4.5

0.0

< 12 less than 12 years of education; 12+ 12 years of education or more
NHW Non-Hispanic Whites; NHB Non-Hispanic Blacks
APC Average annual percentage change
95%-CI 95% Confidence intervals
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Fig. 2 Adjusted amenable mortality rate (X100,000) due to cancer of the skin and cancer of the trachea, bronchus, and lung with Joinpoint
Regression (modeled line of trends) among NHW & NHB by gender, period and education level. United States, 1989–2018. < 12: less than 12 years
of education; 12+: 12 years of education or more. NHW: Non-Hispanic Whites; NHB: Non-Hispanic Blacks

type. Analyzing age-and-sex adjusted 5-year periods
eliminated slight variations that might have occurred in
a particular year, state, or race. While we cannot rule
out a birth cohort influence, on many cancer type mortality rates, since recent research has demonstrated an
increasing trend of cancer incidence among young adults

in the US due to variation in risk factor frequency [43]
the impact on our results are likely negligible.
The strength of using the level of education as an
SES factor in health research lies in its lifetime stability and inclusiveness of measurement. Education is
less likely to be influenced by adulthood health or

Barcelo et al. BMC Cancer
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Fig. 3 Adjusted amenable mortality rate (X100,000) due to Hodgkin’s disease and leukemia, with Joinpoint Regression (modeled line of trends),
among NHW & NHB by gender, period and education level. United States, 1989–2018. < 12: less than 12 years of education; 12+: 12 years of
education or more. NHW: Non-Hispanic Whites; NHB: Non-Hispanic Blacks

income. Higher education is considered a good predictor of improved lifestyles and behaviors, better
jobs, housing, working conditions, and income [4, 44–
46]. Conversely, the effect of education might have
different meanings and returns across the racial
spectrum of the U.S. population. Having less than a
12th grade education is one of the greatest SES contributors to premature mortality when considering
poverty, low social support, income, racial segregation,
and health insurance [11, 30, 31, 47].

Implementing evidence-based programs focused on
social factors such as education and environmental context to reduce cancer screening disparities between NHB
and NHW is recommended [40, 48]. Although recent
statistics suggest lower (or comparable) death rates
among NHW and NHB due to certain cancers such as
breast, prostate, cervix, colon and rectum [7], our data
showed that this decrease was only apparent in some
segments of the U.S. population, i.e., the most educated
NHW. In particular, melanoma of the skin and cancer of

Barcelo et al. BMC Cancer
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Fig. 4 Adjusted amenable mortality rate (X100,000) due to cancer of the testis and prostate cancer with Joinpoint Regression (modeled line of
trends), among NHW & NHB males by period and education level. United States, 1989–2018. < 12: less than 12 years of education; 12+: 12 years of
education or more. NHW: Non-Hispanic Whites; NHB: Non-Hispanic Blacks

the testis has been reported to be more frequent among
NHW than among NHB [49].
Many risk factors have been identified as causing cancer mortality disparities among U.S. racial groups [50].
Lower SES was related to lower awareness for breast
cancer symptoms and prevention [17, 51], resulting in
more advanced stage cancer presentations at diagnosis
than disparities in treatment or access to health insurance [16, 17, 22, 52–55].
Age-adjusted cancer mortality of three types of cancers
(leukemia, breast, and body of the uterus) was found to
be higher among the most educated NHB than their
least educated peers. Age-adjusted mortality rates for the
body of the uterus cancer showed a steady increase in all
subpopulation groups. Although our data suggest the influence of education (attaining 12 years or more) on
mortality rates for most major cancers, this factor did
not appear to have the same detrimental effect on cancer
deaths from leukemia, breast, and body of the uterus
among NHB women. While access to oral contraceptive
use [56] or hormone replacement therapy [57] may play
a role in this issue, it is likely an interaction of other important risk factors. Incidence studies have demonstrated lower breast cancer incidence among NHB

women than NHW women [7, 58]. Additionally, breast
cancer mortality rates have been reported to be more
than 30% higher among NHB than among NHW women
[47]. It is also possible that we missed some of the
known race specific breast cancer differences since we
did not analyze the age-specific rate by race and education. For instance, the presentation of triple negative aggressive breast cancer among young age NHB women
that appears later in life among NHW women [59, 60].
A lower proportion of women of color compared to
NHW women reported having mammography during
the previous 2 years [61]. Our data showed that breast
cancer and cancer of the uterus age-adjusted mortality
rates among the most educated NHB women, between
the age of 25 and 44 years (data not shown), were
slightly lower than their least educated peers. These
findings indicate that the increase in breast and uterine
cancer mortality among the most educated NHB may be
the result of greater mortality among postmenopausal
women (data not shown) compared to women before
the age of 45 years of age, due to greater likelihood of
hormone replacement therapy use among members of
this group. A decreased use of hormone replacement
therapy has been related to a lower incidence of breast
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Fig. 5 Adjusted amenable mortality rate (X100,000) due to breast, cervix uteri, and body of uterus cancer, with Joinpoint Regression (modeled
line of trends), among NHW & NHB females by period and education level. United States, 1989–2018. < 12: less than 12 years of education; 12+:
12 years of education or more. NHW: Non-Hispanic Whites; NHB: Non-Hispanic Blacks

cancer among NHW women [62]. Other factors that
may be involved in the observed differences are limited
availability of community mammography facilities [22],
increased delays in cancer treatment among women of
color, and lack of health insurance [63]. NHB women
living in low SES areas showed poorer breast cancer outcomes than NHW women who were recipients of the
same government-subsidized health services, even after
adjusting by the level of education [64].

Research exploring the complex multi-factorial causes
such as biological, social, health system factors, hormone
replacement therapy, and contraceptive use may help explain our findings [49, 56, 57, 65–71].
The Global Burden of Disease (GDB) study showed
that country cancer profiles depend on the combination
of different exposures to risk factors and socioeconomic
and health care access conditions [72]. The prevention
of cancer mortality in underserved populations requires
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Fig. 6 Adjusted amenable mortality rate (X100,000) due to all other types of cancer, with Joinpoint Regression (modeled line of trends), among
NHW & NHB, by gender, period and education level. United States, 1989–2018. < 12: less than 12 years of education; 12+: 12 years of education or
more. NHW: Non-Hispanic Whites; NHB: Non-Hispanic Blacks

increasing healthcare coverage and outreach programs
to overcome barriers related to stigma, clinician implicit
bias, and nihilism [73]. Furthermore, this disparity demonstrates a need for culturally appropriate cancer prevention interventions tailored to the unique demands of
the most vulnerable groups in the U.S. population for
success [40].
In summary, we reported an increasing gap in the ageadjusted cancer mortality among the most and the least
educated NHW and NHB between 25 and 74 years of
age. These deaths are amenable to access to quality
health care improvement. We also found that the most
educated NHW had lower mortality rates for most malignancies than the less-educated NHW and their most
educated and least educated NHB peers.
Although national statistics reported that the overall
declines in cancer death rates in the U.S. were the result
of significant decreases in four leading cancers (lung,
colorectal, breast, and prostate cancers) [7], our data
showed an increasing trend of cancer mortality among
the least educated NHW and NHB for the same four
(and others) types of cancers. These findings suggest
notable educational and racial disparities in the prevention of cancer incidence, treatment, and mortality
among some segments of the U.S. population, which can
probably be circumvented by increasing access to prevention, screening, and enhanced quality treatment of
cancer among some sub-populations. We also demonstrated that although NHB exhibited the highest age-

adjusted mortality rates for most cancer locations, the
greatest gap between the most and the least educated
was shown for NHW.
Decreasing educational and racial health disparities
may improve access to screening, as well as preventive
and quality care for a large segment of the population
and further reduce premature cancer mortality in the
U.S.
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